High dose dexamethasone therapy shows better responses in acute immune thrombocytopenia than in chronic immune thrombocytopenia

References

• Arnold DM, Kelton JG. Current options for the treatment of idiopathic thrombocytopenic purpura. Semin Hematol 2007; 44: s12–s23
   PubMed Web of Science ®Google Scholar
• Cines DB, Blanchette VS. Immune thrombocytopenic purpura. N Engl J Med 2002; 346: 995–1008
   PubMed Web of Science ®Google Scholar
• George JN, Woolf SH, Raskob GE, Wasser JS, Aledort LM, Ballem PJ, Blanchette VS, Bussel JB, Cines DB, Kelton JG. Idiopathic thrombocytopenic purpura: A practice guideline developed by explicit methods for the American Society of Hematology. Blood 1996; 88: 3–40
   PubMed Web of Science ®Google Scholar
• British Committee for Standards in Haematology General Haematology Task Force. Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy. Br J Haematol 2003; 120: 574–596
   PubMed Web of Science ®Google Scholar
• Andersen JC. Response of resistant idiopathic thrombocytopenic purpura to pulsed high-dose dexamethasone therapy. N Engl J Med 1994; 330: 1560–1564
   PubMed Web of Science ®Google Scholar
• Wang L, Guo CS, Hou M, Li LZ, Zhang CQ, Chen F, Qin P, Peng J, He WD, Chu XX. Combination therapy of thymosin alpha1 and high dose dexamethasone in patients with chronic idiopathic thrombocytopenic purpura. Zhonghua Nei Ke Za Zhi 2007; 46: 274–276
   PubMedGoogle Scholar
• Calabresi AR, Veith RW, Rigby PG. High-dose cycles of dexamethasone in idiopathic thrombocytopenic purpura. J La State Med Soc 2004; 156: 269–272
   PubMedGoogle Scholar
• Borst F, Keuning JJ, van Hulsteijn H, Sinnige H, Vreugdenhil G. High-dose dexamethasone as a first- and second-line treatment of idiopathic thrombocytopenic purpura in adults. Ann Hematol 2004; 83: 764–768
   PubMed Web of Science ®Google Scholar
• Cheng Y, Wong RS, Soo YO, Chui CH, Lau FY, Chan NP, Wong WS, Cheng G. Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone. N Engl J Med 2003; 349: 831–836
   PubMed Web of Science ®Google Scholar
• Stasi R, Brunetti M, Pagano A, Stipa E, Masi M, Amadori S. Pulsed intravenous high-dose dexamethasone in adults with chronic idiopathic thrombocytopenic purpura. Blood Cells Mol Dis 2000; 26: 582–586
   PubMed Web of Science ®Google Scholar
• Gutiérrez-Espíndola GR, Morales-Polanco MR, Guerrero-Rivera S, Talavera JO, Sánchez-Valle E, Gómez-Morales E, Pizzuto-Chávez J. High doses of dexamethasone in adult patients with idiopathic thrombocytopenic purpura. Arch Med Res 2003; 34: 31–34
   PubMedGoogle Scholar
• Hedlund-Treutiger I, Henter JI, Elinder G. Randomized study of IVIg and high-dose dexamethasone therapy for children with chronic idiopathic thrombocytopenic purpura. J Pediatr Hematol Oncol 2003; 25: 139–144
   PubMedGoogle Scholar
• Wali YA, Al Lamki Z, Shah W, Zacharia M, Hassan A. Pulsed high-dose dexamethasone therapy in children with chronic idiopathic thrombocytopenic purpura. Pediatr Hematol Oncol 2002; 19: 329–335
   PubMed Web of Science ®Google Scholar
• Chandra J, Dua T, Narayan S, et al. Dexamethasone Therapy in Chronic ITP. Indian Pediatrics 2000; 37: 647–650
   PubMedGoogle Scholar
• Kühne T, Freedman J, Semple JW, Doyle J, Butchart S, Blanchette VS. Platelet and immune responses to oral cyclic dexamethasone therapy in childhood chronic immune thrombocytopenic purpura. J Pediatr 1997; 130: 17–24
   PubMed Web of Science ®Google Scholar
• Van Riet FA, Wessels G, Hesseling PB. Experience with high dose dexamethasone in the treatment of chronic symptomatic immune thrombocytopaenia. East Afr Med J 1999; 76: 571–574
   PubMed Web of Science ®Google Scholar
• Bulvik S, Winder A, Ben-Tal O, Szold A, Eldor A. High-dose dexamethasone for splenectomy in patients with idiopathic thrombocytopenic purpura. Haemostasis 1998; 28: 256–259
   PubMedGoogle Scholar
• Chen JS, Wu JM, Chen YJ, Yeh TF. Pulsed high-dose dexamethasone therapy in children with chronic idiopathic thrombocytopenic purpura. J Pediatr Hematol Oncol 1997; 19: 526–529
   PubMedGoogle Scholar
• Warner M, Wasi P, Couban S, Hayward C, Warkentin T, Kelton JG. Failure of pulse high-dose dexamethasone in chronic idiopathic immune thrombocytopenia. Am J Hematol 1997; 54: 267–270
   PubMed Web of Science ®Google Scholar
• Borgna-Pignatti C, Rugolotto S, Nobili B, Amendola G, De Stefano P, Maccario R, Locatelli F. A trial of high-dose dexamethasone therapy for chronic idiopathic thrombocytopenic purpura in childhood. J Pediatr 1997; 130: 13–16
   PubMed Web of Science ®Google Scholar
• Arruda VR, Annichino-Bizzacchi JM. High-dose dexamethasone therapy in chronic idiopathic thrombocytopenic purpura. Ann Hematol 1996; 73: 175–177
   PubMed Web of Science ®Google Scholar
• Caulier MT, Rose C, Roussel MT, Huart C, Bauters F, Fenaux P. Pulsed high-dose dexamethasone in refractory chronic idiopathic thrombocytopenic purpura: A report on 10 cases. Br J Haematol 1995; 91: 477–479
   PubMed Web of Science ®Google Scholar
• Dubbeld P, van der Heul C, Hillen HF. Effect of high-dose dexamethasone in prednisone-resistant autoimmune thrombocytopenic purpura (ITP). Neth J Med 1991; 39: 6–10
   PubMedGoogle Scholar
• Mazzucconi MG, Fazi P, Bernasconi S, De Rossi G, Leone G, Gugliotta L, Vianelli N, Avvisati G, Rodeghiero F, Amendola A. Therapy with high-dose dexamethasone (HD-DXM) in previously untreated patients affected by idiopathic thrombocytopenic purpura: A GIMEMA experience. Blood 2007; 109: 1401–1407
   PubMed Web of Science ®Google Scholar
• Baronci C, Pansini V, Funaro D, Coletti V, Caruso R, De Rossi G. Idiopathic thrombocytopenic purpura (ITP) in children. Pediatr Blood Cancer 2006; 47: 665–667
   PubMedGoogle Scholar